Literature DB >> 12679926

Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H. pylori infection in patients with precancerous lesions.

Shao Li1, Ai-Ping Lu, Lian Zhang, Yan-Da Li.   

Abstract

AIM: To determine the prevalence of Helicobacter pylori (H. pylori) infection, the serum anti-H. pylori immunoglobulin G (IgG) and IgA antibody responses, and the value of clinical presentations in diagnosis of H. pylori infection in patients with gastric atrophy, intestinal metaplasia and dysplasia.
METHODS: H. pylori infection was detected by histology in 209 patients with mild chronic atrophic gastritis (CAG, n=76), severe CAG (n=22), mild intestinal metaplasia (IM, n=22), severe IM (n=58), or dysplasia (DYS, n=31). Serum anti-H. pylori IgG and IgA were double sampled and evaluated by enzyme-linked immunoadsordent assays. 35 clinical presentations were observed and their relationship with H. pylori infection was analyzed by the k-means cluster method.
RESULTS: Both IgG and IgA levels in H. pylori positive patients were significantly higher than those negative for H. pylori (P<0.001-0.01). The prevalence of H. pylori was highest in severe IM (84.5 %), and lowest in mild CAG (51.3 %) (P<0.01). They were similar in severe CAG (68.2 %), mild IM (72.7 %), and DYS (67.7 %). In H. pylori positive patients, the IgG levels in severe CAG were significantly higher than those in mild CAG (P<0.01). In H. pylori negative patients, both IgG and IgA levels increased remarkably in severe IM, compared to those in mild IM (P<0.01-0.05). H. pylori infection exhibited no association with patient's gender (62.1 % in males; 71.7 % in females) and age (r=0.0814, P=0.241). The diagnostic accuracy based on 35 clinical presentations was 65.7 %. It could be improved by 5.7 % when only the assemblage of digestive symptoms were engaged, or by 8.6 % when the pathogenic factors, general status and grossoscopy were combined. The diagnostic accuracy could be decreased when only the general symptoms were engaged, or when the pathogenic factors were accompanied with some common digestive symptoms.
CONCLUSION: H. pylori infection is a major risk factor for the process from atrophy, IM to DYS of gastric mucosa. Serum IgG and IgA are good indicators to evaluate this progress with a certain arrearage. Investigation on the effective assemblages of clinical presentations may provide a better understanding in the pathogenesis, diagnosis and treatment for H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679926      PMCID: PMC4611444          DOI: 10.3748/wjg.v9.i4.755

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

1.  Effect of Helicobacter pylori infection on gastric epithelial cell proliferation.

Authors:  Hong Gao; Ji-Yao Wang; Xi-Zhong Shen; Jian-Jun Liu
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions:H.pylori infection, histological types and staging.

Authors:  Heng-Jun Gao; Lian-Zhen Yu; Jian-Feng Bai; Yan-Shen Peng; Gu Sun; Han-Lin Zhao; Kun Miu; Xiu-Zhen L ; Xiao-Yong Zhang; Zhi-Quan Zhao
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

3.  Close correlation of intestinal metaplasia and corpus gastritis in patients infected with Helicobacter pylori.

Authors:  A Meining; M Stolte
Journal:  Z Gastroenterol       Date:  2002-08       Impact factor: 2.000

Review 4.  Helicobacter pylori: recent advances in the study of its pathogenicity and prevention.

Authors:  G R Aguilar; G Ayala; G Fierros-Zárate
Journal:  Salud Publica Mex       Date:  2001 May-Jun

5.  Clinical and experimental study of therapeutic effect of Weixibaonizhuan pills on gastric precancerous lesions.

Authors:  Xu-Chen Zhang; Rui-Feng Gao; Bing-Qing Li; Lian-Sheng Ma; Li-Xin Mei; Yu-Zhen Wu; Feng-Qin Liu; Zheng-Lin Liao
Journal:  World J Gastroenterol       Date:  1998-02       Impact factor: 5.742

6.  Helicobacter pylori antigen and its IgG, IgA -type specific immunocomplexes in sera from patients with Helicobacter pylori infection.

Authors:  Yongliang Zhu; Jie Lin; Da Li; Qin Du; Keda Qian; Qindong Wu; Shu Zheng
Journal:  Chin Med J (Engl)       Date:  2002-03       Impact factor: 2.628

7.  Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation.

Authors:  C Prinz; M Schöniger; R Rad; I Becker; E Keiditsch; S Wagenpfeil; M Classen; T Rösch; W Schepp; M Gerhard
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

8.  A diagnostic dilemma for chronic rhinosinusitis: definition accuracy and validity.

Authors:  James A Stankiewicz; James M Chow
Journal:  Am J Rhinol       Date:  2002 Jul-Aug

Review 9.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.

Authors:  M F Dixon; R M Genta; J H Yardley; P Correa
Journal:  Am J Surg Pathol       Date:  1996-10       Impact factor: 6.394

10.  The role of environmental factors in medically unexplained symptoms and related syndromes: conference summary and recommendations.

Authors:  Howard M Kipen; Nancy Fiedler
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

View more
  11 in total

Review 1.  Current situation and progress in integrative medicine in China.

Authors:  Ai-ping Lu; Xiao-rong Ding; Ke-ji Chen
Journal:  Chin J Integr Med       Date:  2008-10-14       Impact factor: 1.978

2.  Helicobacter infection in hepatocellular carcinoma tissue.

Authors:  Shi-Ying Xuan; Ning Li; Xin Qiang; Rong-Rong Zhou; Yong-Xin Shi; Wen-Jie Jiang
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

3.  The best method of detecting prior Helicobacter pylori infection.

Authors:  Chien-Yu Lu; Chao-Hung Kuo; Yi-Ching Lo; Hung-Yi Chuang; Yuan-Chieh Yang; I-Chen Wu; Fang-Jong Yu; Yi-Chen Lee; Chang-Ming Jan; Wen-Ming Wang; Deng-Chyang Wu
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

4.  Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection.

Authors:  Chuan-Yong Guo; Yun-Bin Wu; Heng-Lu Liu; Jian-Ye Wu; Min-Zhang Zhong
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

5.  Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma.

Authors:  Rinaldo Pellicano; Vincenzo Mazzaferro; Walter Franco Grigioni; Miguel Angel Cutufia; Sharmila Fagoonee; Lorenzo Silengo; Mario Rizzetto; Antonio Ponzetto
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

6.  Impact of Coinfection with Schistosoma mansoni on the Antibody Response to Helicobacter pylori.

Authors:  Ashraf Fawzy Mosa Ahmed; Mona Hassan El-Sayad; Hala Shehata Ali; Hend Aly El-Taweel
Journal:  Acta Parasitol       Date:  2021-02-17       Impact factor: 1.440

7.  Misdiagnosis and undiagnosis due to pattern similarity in Chinese medicine: a stochastic simulation study using pattern differentiation algorithm.

Authors:  Arthur Sá Ferreira
Journal:  Chin Med       Date:  2011-01-12       Impact factor: 5.455

Review 8.  Diagnosis of Helicobacter pylori Using Invasive and Noninvasive Approaches.

Authors:  Amin Talebi Bezmin Abadi
Journal:  J Pathog       Date:  2018-05-22

9.  Symptomatic comparison in efficacy on patients with benign prostatic hyperplasia treated with two therapeutic approaches.

Authors:  Shao Li; Aiping Lu; Yongyan Wang
Journal:  Complement Ther Med       Date:  2009-12-02       Impact factor: 2.446

10.  Correlation of serum anti-helicobacter pylori immunoglobulin a (IgA) with histological parameters of chronic gastritis in ibadan, Nigeria.

Authors:  Ao Oluwasola; Ja Otegbayo; So Ola; Ho Ebili; Ao Afolabi; Gn Odaibo
Journal:  Ann Ib Postgrad Med       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.